ATR
N/A
Summary:
NeuBase Therapeutics average true range is not available.NBSE ATR Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE ATR Performance
| PeriodPeriod | ATRATR | PricePrice | 200-day SMA200-day SMA | SPXSPX |
|---|---|---|---|---|
| todaytoday | - | - | - | -1.1% |
| 1 m1 month | - | - | - | -0.5% |
| 3 m3 months | - | - | - | +4.0% |
| 6 m6 months | - | - | - | +8.9% |
| ytdytd | - | - | - | +25.2% |
| 1 y1 year | - | - | - | +24.9% |
| 5 y5 years | - | - | - | +84.3% |
NBSE ATR High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | $0.13 | $0.01 | ||
| 3 y | 3 years | $5.94 | $0.01 | ||
| 5 y | 5 years | $20.06 | $0.01 | ||
| alltime | all time | $813.56 | $0.00 |
NeuBase Therapeutics ATR History
| Date | Value |
|---|---|
| 2023 | $0.10(-88.7%) |
| 2022 | $0.86(-83.5%) |
| 2021 | $5.22(-52.7%) |
| 2020 | $11.04(+15.1%) |
| 2019 | $9.60(+49.6%) |
| 2018 | $6.42(-91.2%) |
| 2017 | $72.68(+35.0%) |
| 2016 | $53.85(-70.5%) |
| 2015 | $182.47(+40.9%) |
| 2014 | $129.55(+35.3%) |
| Date | Value |
|---|---|
| 2013 | $95.72(-2.9%) |
| 2012 | $98.56(+93.8%) |
| 2011 | $50.86(+130.2%) |
| 2010 | $22.09(-57.8%) |
| 2009 | $52.30(+4088.3%) |
| 2008 | $1.25(-65.0%) |
| 2007 | $3.56(>+9900.0%) |
| 2006 | $0.04(-90.1%) |
| 2005 | $0.36(-98.1%) |
| 2004 | $18.71 |
FAQ
- What is the all time high ATR for NeuBase Therapeutics?
What is the all time high ATR for NeuBase Therapeutics?
NeuBase Therapeutics all-time high average true range is $813.56